| GO |
B_12_15 |
GO:0140374 |
antiviral innate immune response |
7/28 |
59/18986 |
2.17918917683643e-12 |
1.18072431763137e-10 |
7.2778662460853e-11 |
EIF2AK2/IFIT2/IFIT3/MX1/OAS1/OAS2/OAS3 |
7 |
| GO |
B_12_15 |
GO:0140888 |
interferon-mediated signaling pathway |
8/28 |
112/18986 |
3.20570450972671e-12 |
1.59216657316426e-10 |
9.81395503416334e-11 |
IFITM1/IRF7/ISG15/OAS1/OAS2/OAS3/PARP9/STAT1 |
8 |
| MeSH_gene2pubmed |
B_12_15 |
D009522 |
Newcastle disease virus |
6/30 |
43/26076 |
8.05651267677087e-12 |
1.52049530589436e-09 |
9.8680325653912e-10 |
IFIT2/IFITM1/IRF7/IRF9/STAT1/TNFSF10 |
6 |
| MeSH_gene2pubmed |
B_12_15 |
D050838 |
Interferon Regulatory Factor-3 |
8/30 |
160/26076 |
8.79063402915361e-12 |
1.52049530589436e-09 |
9.8680325653912e-10 |
EIF2AK2/IRF7/IRF9/ISG15/OAS1/STAT1/TNFSF10/UBE2L6 |
8 |
| GO |
B_12_15 |
GO:0032479 |
regulation of type I interferon production |
8/28 |
128/18986 |
9.49486125618079e-12 |
4.04209807763125e-10 |
2.49150870556924e-10 |
IRF7/ISG15/NMI/OAS1/OAS2/OAS3/STAT1/XAF1 |
8 |
| GO |
B_12_15 |
GO:0032606 |
type I interferon production |
8/28 |
128/18986 |
9.49486125618079e-12 |
4.04209807763125e-10 |
2.49150870556924e-10 |
IRF7/ISG15/NMI/OAS1/OAS2/OAS3/STAT1/XAF1 |
8 |
| MeSH_gene2pubmed |
B_12_15 |
D008251 |
Macaca |
9/30 |
259/26076 |
9.76392763796047e-12 |
1.52049530589436e-09 |
9.8680325653912e-10 |
EIF2AK2/IFI44/IFIT3/IRF7/ISG15/MX1/STAT1/TNFSF10/TRIM22 |
9 |
| MeSH_gene2pubmed |
B_12_15 |
D012330 |
RNA, Double-Stranded |
10/30 |
387/26076 |
1.06518681252074e-11 |
1.52049530589436e-09 |
9.8680325653912e-10 |
EIF2AK2/IFIT2/IRF7/IRF9/ISG15/OAS1/OAS2/OAS3/STAT1/TNFSF10 |
10 |
| MeSH_gene2pubmed |
B_12_15 |
D009980 |
Influenza A virus |
8/30 |
164/26076 |
1.07254468225153e-11 |
1.52049530589436e-09 |
9.8680325653912e-10 |
EIF2AK2/IRF7/IRF9/ISG15/MX1/MX2/STAT1/TNFSF10 |
8 |
| GO |
B_12_15 |
GO:0019079 |
viral genome replication |
8/28 |
130/18986 |
1.07661132651017e-11 |
4.27773567066709e-10 |
2.63675335404948e-10 |
EIF2AK2/IFITM1/ISG15/MX1/OAS1/OAS2/OAS3/PLSCR1 |
8 |